These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. On the relationship between initiator and effector cells in the response to major tansplantation antigens. Howard JC Transplant Proc; 1973 Dec; 5(4):1451-6. PubMed ID: 4130057 [No Abstract] [Full Text] [Related]
5. [Organ transplantation. I. Genetics and immunology]. Häyry P Duodecim; 1977; 93(18):1135-51. PubMed ID: 22430 [No Abstract] [Full Text] [Related]
6. The Graft-versus-Host Reaction: a pathogenetic mechanism of experimental and human disease. Seemayer TA Perspect Pediatr Pathol; 1979; 5():93-136. PubMed ID: 43960 [No Abstract] [Full Text] [Related]
7. Functional ontogeny of human lymphoid cells as a factor in maternal-fetal tolerance. Siegal FP Prog Clin Biol Res; 1981; 70():41-6. PubMed ID: 6458825 [No Abstract] [Full Text] [Related]
9. Xenotransplantation and ABO incompatible transplantation: the similarities they share. Galili U Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361 [TBL] [Abstract][Full Text] [Related]
10. Specificity of cell-mediated transplantation reactions. I. Studies with the technique of inhibition of migration and an assay of tumour immunity in vivo. Lake P; Sabbadini E; Sehon AH Immunology; 1974 Sep; 27(3):427-39. PubMed ID: 4137936 [TBL] [Abstract][Full Text] [Related]
11. Genetic determinants for the graft-vs.-host reaction in the H-2 complex. Oppltová L; Démant P Transplant Proc; 1973 Dec; 5(4):1367-71. PubMed ID: 4149545 [No Abstract] [Full Text] [Related]
12. Maternal modification of tissue antigenicity and the graft-versus-host reaction. Uphoff DE Rev Eur Etud Clin Biol; 1970 Jan; 15(1):84-7. PubMed ID: 4392612 [No Abstract] [Full Text] [Related]
13. The problems and practice of bone marrow transplantation in man: the severe combined immunodeficiency syndrome as the ideal model. Levey RH Transplant Proc; 1972 Dec; 4(4):565-6. PubMed ID: 4405148 [No Abstract] [Full Text] [Related]
14. Soluble H-2 antigens: effect on graft-versus-host reaction and factors influencing its effect on host-versus-skin-graft reaction. Halle-Pannenko O; Martyre MC; Mathé G Transplant Proc; 1972 Dec; 4(4):517-21. PubMed ID: 4405145 [No Abstract] [Full Text] [Related]
15. Immunosuppression and malignant lymphomas in graft-versus-host reactions. Solnik C; Gleichmann H; Kavanah M; Schwartz RS Cancer Res; 1973 Sep; 33(9):2068-77. PubMed ID: 4146854 [No Abstract] [Full Text] [Related]
19. Genetic and cellular control of in vitro models of allograft reactivity. Bach FH; Alter BJ; Schendel DJ; Segall M; Bach ML Birth Defects Orig Artic Ser; 1975; 11(1):467-76. PubMed ID: 238687 [TBL] [Abstract][Full Text] [Related]
20. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation. Li JM; Waller EK Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]